CCND1 and breast carcinoma: The role of ROS in breast cancer is based on intracellular levels; at low levels, ROS can promote proliferation in cancer by stimulating cyclin D1 expression, triggering ERK phosphorylation and MAPK activation, which are all associated with carcinogenesis and cancer cell survival [32–35].